BridgeMD
New treatment option for Periodontal Defect
Official title Effect of Collagen Membranes on Distal Periodontal Healing of Second Molars After Impacted Mandibular Third Molar Surgery.
ClinicalTrials.gov ID: NCT07114523
What this study is testing
- What it's testing
- Impacted mandibular third molars can cause various complications to the adjacent second molars, such as dental caries, periodontitis, or root resorption. These complications often progress silently and asymptomatically.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 and older
You may be able to join if
- Patients aged 25 years or older.
- Patients with mesioangular or horizontally impacted mandibular third molars. The highest point of mandibular third molars are lower than the occlusal...
- Patients with symmetrical lower third molars on both sides with same classification according to Pell - Gregory's category. The difference of third...
- Patients with lower second molars on both sides have no cavities or fillings that affect the determination of the cemento-enamel junction.
- Patients are explained, counseled clearly and sign their consent to participate in the study.
You likely can't join if
- Patients with coagulation or immune disorders.
- Patients allergic to local anesthetics (Lidocaine 2% with Adrenaline 1:100,000) or any drugs used in the study.
- Patients allergic to products or food derived from pigs.
- Pregnant or breastfeeding patients.
- Patients who smoke.
- Patients with systemic conditions that contraindicate surgical procedures.
See the full eligibility criteria
- Patients aged 25 years or older.
- Patients with mesioangular or horizontally impacted mandibular third molars. The highest point of mandibular third molars are lower than the occlusal surface of adjacent second molars (classified B, C according to Pell...
- Patients with symmetrical lower third molars on both sides with same classification according to Pell - Gregory's category. The difference of third molars inclination on both side is not more than 15°.
- Patients with lower second molars on both sides have no cavities or fillings that affect the determination of the cemento-enamel junction.
- Patients are explained, counseled clearly and sign their consent to participate in the study.
- Patients with coagulation or immune disorders.
- Patients allergic to local anesthetics (Lidocaine 2% with Adrenaline 1:100,000) or any drugs used in the study.
- Patients allergic to products or food derived from pigs.
- Pregnant or breastfeeding patients.
- Patients who smoke.
- Patients with systemic conditions that contraindicate surgical procedures.
- Patients with clinical or radiographic signs suggestive of tumors (benign or malignant) associated with or in proximity to the mandibular third molar.
- Patients with missing mandibular second molars.
The study team makes the final eligibility decision.
Where it's taking place
- Ho Chi Minh City, Vietnam
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 25 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ho Chi Minh City, Vietnam. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.